Clinical Trial Update: Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 safety study of BMS-986202 in healthy subjects and its evaluation for psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BMS-986202

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 1 | Status: COMPLETED